Low-dose ITI Strategy for Children in Hemophilia A With High-titer Inhibitor and Poor ITI Risk in China
Status:
Unknown status
Trial end date:
2020-12-01
Target enrollment:
Participant gender:
Summary
The study start on January 18, 2017. The Severe(FⅧ<1%) and moderate hemophilia A
(FⅧ1%～5%)children with high titer inhibitor(historical peak inhibitor titer≥5BU ) combining
with poor ITI risk(s) were enrolled. The low-dose ITI was alone or combined with
immunosuppression.